Genstar Capital, a private equity firm, acquired Advarra from Linden Capital Partners, another private equity house. Advarra offers institutional review board, institutional biosafety committee, and research quality and compliance services.
Genstar focuses on investments in targeted markets of the healthcare, software, industrial technology, and financial services industries. Linden will actually reinvest for a minority position post the transaction. Advarra was created upon the merger in 2017 of Chesapeake IRB and Schulman.